Allengers' Digital C-ARM with 3D clears the FDA in the mobile fluoroscopy lane

On June 5, 2026, the FDA cleared the Digital C-ARM with 3D from Allengers Medical Systems Limited through the 510(k) pathway, recording the decision as clearance number K253296. The submission was a Traditional 510(k) received on September 29, 2025 and found Substantially Equivalent. The device sits in the Radiology advisory panel under product code OXO, regulation 892.1650, as a Class II device.

A C-arm is the mobile, C-shaped imaging system that wheels into operating rooms and procedure suites to provide real-time X-ray guidance during surgery. Allengers' entry adds a 3D capability — the ability to reconstruct volumetric images from a rotational acquisition — to the familiar mobile fluoroscopy platform. The FDA's classification for OXO describes the underlying device type's purpose with characteristic economy.

"Fluoroscopy of the human body."— FDA Product Classification, product code OXO, source

Four words, but they carry the entire intended use: real-time X-ray imaging of internal anatomy. The full product-code title — 'Image-Intensified Fluoroscopic X-Ray System, Mobile' — adds the form factor (mobile) and the imaging chain (image-intensified fluoroscopy). Everything else about the clearance, including the 3D feature, has to fit inside that established category.

The landscape signal: who is filing

The most interesting thing about this clearance is not the device but the applicant. Allengers Medical Systems Limited is an India-based imaging-equipment manufacturer, and its appearance in the OXO product code is a data point in a longer trend: imaging hardware that was once dominated by a handful of incumbent multinationals is increasingly being cleared by manufacturers based outside the traditional US/EU/Japan core. A 510(k) clearance is the entry ticket to the US market, and a non-US manufacturer clearing a 3D-capable mobile C-arm is a marker of where the imaging-hardware supply base is diversifying.

For a landscape analyst, the OXO product code is the right altitude from which to read this. The code binds Allengers' device to the same regulation (892.1650), the same Class II posture, and the same image-intensified-fluoroscopy device type that the established players' mobile C-arms occupy. Clearing into that code means Allengers is asserting substantial equivalence to a US-marketed predicate — competing on the incumbents' regulatory terms, not on a novel category of its own.

What 'with 3D' does and does not change

The '3D' in the device name is a capability claim, and it is worth being precise about what it implies within a 510(k). Adding volumetric reconstruction to a mobile C-arm is a meaningful feature for surgical guidance — it lets a clinician review anatomy in three dimensions intraoperatively rather than relying solely on 2D projections. But within the OXO classification, the device is still fundamentally an image-intensified fluoroscopic X-ray system. The 3D feature is an enhancement layered onto the cleared device type, not a reclassification into a different regulation such as computed tomography.

That distinction matters for anyone reading clearance announcements as competitive intelligence. A 3D-capable C-arm cleared under OXO is positioned against other mobile fluoroscopy systems, not against fixed CT scanners. The Traditional 510(k) route, and the roughly eight-month review from a September 29, 2025 receipt to a June 5, 2026 decision, are consistent with a feature-bearing device that nonetheless had to demonstrate substantial equivalence across a full data set rather than a minor modification.

Why a four-word definition is enough

It is easy to read 'Fluoroscopy of the human body' as the FDA being terse, but the brevity is a feature of how device classification works. The product code's job is to bind a device to a regulation and a Class so that the right special controls and the right predicate comparison apply; it does not need to describe every capability a given product layers on top. The four-word function statement establishes the regulated purpose — real-time X-ray imaging of internal anatomy — and the full code title adds that the system is image-intensified and mobile. Everything Allengers built into this particular unit, including 3D reconstruction, has to be demonstrated as substantially equivalent within that purpose, not as a departure from it.

That is why a strategist should treat the product code, not the device name, as the anchor. 'Digital C-ARM with 3D' is a marketing description that signals a feature; OXO, regulation 892.1650, Class II, Radiology is the regulatory reality that determines what predicate the device was measured against and what claims it can support. A clearance announcement that leads with '3D' is selling the feature; the code is what fixes the category.

The supply-base trend worth tracking

For landscape analysis, the recurring value in clearances like this is cumulative. Any single 510(k) from a non-incumbent imaging manufacturer is a single data point. But a steady stream of such clearances — feature-rich mobile imaging systems cleared by manufacturers based outside the historical US/EU/Japan core — would describe a real shift in where capital-equipment imaging is designed and built. The way to read that trend is exactly through the product code: when new entrants cluster into the established codes that incumbents occupy, they are competing head-on within the same regulatory category rather than carving out a novel one. Allengers clearing a 3D-capable system into OXO is one such cluster point.

What the record establishes

The openFDA entry fixes, verbatim, that the Digital C-ARM with 3D is Allengers' device, cleared June 5, 2026 as K253296, determined Substantially Equivalent through a Traditional 510(k), and classified as Class II in the Radiology panel under product code OXO (regulation 892.1650). The classification record supplies the function statement quoted above. The named predicate, the radiation-dose and image-quality performance, and the specifics of the 3D reconstruction live in the full 510(k) summary, which is the canonical detail record.

The durable read is twofold. First, the device's intended use is exactly what the regulation says: image-intensified fluoroscopy of the human body, in a mobile form factor, now with a 3D capability layered on. Second, and more strategically, the applicant is the story — a non-incumbent imaging manufacturer clearing a feature-rich mobile C-arm for the US market is a small but real marker of how the imaging-hardware landscape is broadening beyond its traditional players.